|
US1011184A
(en)
|
1909-10-18 |
1911-12-12 |
Joseph H Godfrey |
Bottle-filling device.
|
|
US1009252A
(en)
|
1910-11-26 |
1911-11-21 |
Michael E Mallo |
Carbureter.
|
|
US1013709A
(en)
|
1911-05-22 |
1912-01-02 |
New Orleans Specialty Co |
Game apparatus.
|
|
US2304669A
(en)
|
1940-08-16 |
1942-12-08 |
Adams Roger |
Isolation of cannabidiol
|
|
JPS5430146A
(en)
|
1977-08-05 |
1979-03-06 |
Microbial Chem Res Found |
Novel anthracycline derivatives and their preparation
|
|
GB9726916D0
(en)
|
1997-12-19 |
1998-02-18 |
Danbiosyst Uk |
Nasal formulation
|
|
EP1071419B1
(en)
*
|
1998-04-21 |
2007-07-25 |
THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Cannabinoids as antioxidants and neuroprotectants
|
|
US6403126B1
(en)
|
1999-05-26 |
2002-06-11 |
Websar Innovations Inc. |
Cannabinoid extraction method
|
|
US6949582B1
(en)
|
1999-05-27 |
2005-09-27 |
Wallace Walter H |
Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment
|
|
IL136839A
(en)
|
2000-06-16 |
2006-12-10 |
Yissum Res Dev Co |
Pharmaceutical compositions comprising cannabidiol derivatives, and processes for the preparation of same
|
|
DE10051427C1
(de)
|
2000-10-17 |
2002-06-13 |
Adam Mueller |
Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte
|
|
DK1361864T3
(en)
|
2001-02-14 |
2014-03-03 |
Gw Pharma Ltd |
FLYLDENDE SPRAY FORMULATIONS FOR buccal administration of cannabinoids
|
|
GB2377633A
(en)
|
2001-05-11 |
2003-01-22 |
Gw Pharmaceuticals Ltd |
Pharmaceutical compositions comprising the cannabinoids THC and CBD
|
|
US7025992B2
(en)
|
2001-02-14 |
2006-04-11 |
Gw Pharma Limited |
Pharmaceutical formulations
|
|
GB2381194A
(en)
|
2001-09-07 |
2003-04-30 |
Gw Pharmaceuticals Ltd |
Pharmaceutical formulations
|
|
GB2380129B
(en)
|
2001-02-14 |
2004-08-11 |
Gw Pharma Ltd |
Pharmaceutical formulations
|
|
GB2377218A
(en)
|
2001-05-04 |
2003-01-08 |
Gw Pharmaceuticals Ltd |
Process and apparatus for extraction of active substances and enriched extracts from natural products
|
|
GB2381450B
(en)
|
2001-10-31 |
2006-05-31 |
Gw Pharma Ltd |
Compositions for administration of natural or synthetic cannabinoids by vaporisation
|
|
GB0202385D0
(en)
|
2002-02-01 |
2002-03-20 |
Gw Pharma Ltd |
Compositions for the treatment of nausea,vomiting,emesis,motion sicknes or like conditions
|
|
ITPD20020138A1
(it)
|
2002-05-24 |
2003-11-24 |
Matteo Bevilacqua |
Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima.
|
|
DE10226494A1
(de)
|
2002-06-14 |
2004-01-08 |
Lts Lohmann Therapie-Systeme Ag |
Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen
|
|
US6946150B2
(en)
|
2002-08-14 |
2005-09-20 |
Gw Pharma Limited |
Pharmaceutical formulation
|
|
US10538373B2
(en)
|
2002-08-14 |
2020-01-21 |
Gw Pharma Limited |
Pharmaceutical formulation
|
|
MXPA05001621A
(es)
|
2002-08-14 |
2005-08-19 |
Gw Pharma Ltd |
Extraccion de cannabinoides farmaceuticamente activos de materiales vegetales.
|
|
EP1542657B8
(en)
|
2002-08-14 |
2012-03-14 |
GW Pharma Limited |
Cannabinoid liquid formulations for mucosal amdinistration
|
|
US6986748B2
(en)
|
2002-08-15 |
2006-01-17 |
Scimed Life Systems, Inc. |
Multiple biopsy apparatus and related method of use
|
|
GB0222077D0
(en)
|
2002-09-23 |
2002-10-30 |
Gw Pharma Ltd |
Methods of preparing cannabinoids from plant material
|
|
GB2393182B
(en)
|
2002-09-23 |
2007-03-14 |
Gw Pharma Ltd |
Method of preparing cannabidiol from plant material
|
|
US20040110828A1
(en)
|
2002-11-27 |
2004-06-10 |
Chowdhury Dipak K. |
Tetrahydrocannabinol compositions and methods of manufacture and use thereof
|
|
WO2005065069A2
(en)
|
2003-07-11 |
2005-07-21 |
Myriad Genetics, Inc. |
Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
|
|
IL160420A0
(en)
|
2004-02-16 |
2004-07-25 |
Yissum Res Dev Co |
Treating or preventing diabetes with cannabidiol
|
|
GB2414933B
(en)
|
2004-06-08 |
2009-07-15 |
Gw Pharma Ltd |
Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis
|
|
WO2006017892A1
(en)
|
2004-08-16 |
2006-02-23 |
Northern Sydney And Central Coast Area Health Service |
Methods for improving cognitive functioning
|
|
US9168278B2
(en)
|
2004-11-16 |
2015-10-27 |
Gw Pharma Limited |
Use for cannabinoid
|
|
GB0425248D0
(en)
|
2004-11-16 |
2004-12-15 |
Gw Pharma Ltd |
New use for cannabinoid
|
|
TWI366460B
(en)
|
2005-06-16 |
2012-06-21 |
Euro Celtique Sa |
Cannabinoid active pharmaceutical ingredient for improved dosage forms
|
|
US20070060638A1
(en)
|
2005-08-26 |
2007-03-15 |
Olmstead Mary C |
Methods and therapies for potentiating therapeutic activities of a cannabinoid receptor agonist via administration of a cannabinoid receptor antagonist
|
|
WO2007032962A2
(en)
|
2005-09-09 |
2007-03-22 |
University Of Kentucky |
Compositions and methods for intranasal delivery of tricyclic cannabinoids
|
|
EP2578561A1
(en)
|
2005-09-29 |
2013-04-10 |
Albany Molecular Research, Inc. |
Processes for the production of cannabidiol derivatives and intermediates thereof
|
|
GB2432312A
(en)
|
2005-11-01 |
2007-05-23 |
Gw Pharma Ltd |
Pharmaceutical compositions for the treatment of pain
|
|
GB2434312B
(en)
|
2006-01-18 |
2011-06-29 |
Gw Pharma Ltd |
Cannabinoid-containing plant extracts as neuroprotective agents
|
|
WO2007142957A2
(en)
|
2006-05-30 |
2007-12-13 |
Air Systems |
Gear drive damper
|
|
GB2438682A
(en)
|
2006-06-01 |
2007-12-05 |
Gw Pharma Ltd |
New use for cannabinoids
|
|
US20080112895A1
(en)
|
2006-08-04 |
2008-05-15 |
Insys Therapeutics Inc. |
Aqueous dronabinol formulations
|
|
WO2008021394A2
(en)
|
2006-08-15 |
2008-02-21 |
Theraquest Biosciences, Llc |
Pharmaceutical formulations of cannabinoids and method of use
|
|
US20110150825A1
(en)
|
2006-11-14 |
2011-06-23 |
Pharmacyclics, Inc. |
Uses of selective inhibitors of hdac8 for treatment of inflammatory conditions
|
|
US20080188461A1
(en)
|
2007-02-01 |
2008-08-07 |
Regents Of The University Of Michigan |
Compositions and methods for detecting, preventing and treating seizures and seizure related disorders
|
|
CN101040855A
(zh)
|
2007-04-12 |
2007-09-26 |
杨喜鸿 |
含有利莫那班和泊洛沙姆的组合物、固体分散体及其制备和药物应用
|
|
GB2448535A
(en)
|
2007-04-19 |
2008-10-22 |
Gw Pharma Ltd |
New use for cannabinoid-containing plant extracts
|
|
WO2008144475A1
(en)
|
2007-05-17 |
2008-11-27 |
California Pacific Medical Center |
Methods and compositions for treating cancer
|
|
GB2449691A
(en)
|
2007-05-31 |
2008-12-03 |
Gw Pharma Ltd |
A reference plant lacking medicinal active compound expression
|
|
EP2023121A1
(en)
|
2007-07-06 |
2009-02-11 |
Bp Oil International Limited |
Optical cell
|
|
GB2450753B
(en)
|
2007-07-06 |
2012-07-18 |
Gw Pharma Ltd |
New Pharmaceutical formulation
|
|
DK2176208T3
(en)
*
|
2007-07-30 |
2015-04-27 |
Zynerba Pharmaceuticals Inc |
Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof
|
|
WO2009020666A1
(en)
|
2007-08-06 |
2009-02-12 |
Insys Therapeutics Inc. |
Oral cannabinoid liquid formulations and methods of treatment
|
|
US8222292B2
(en)
|
2007-08-06 |
2012-07-17 |
Insys Therapeutics, Inc. |
Liquid cannabinoid formulations
|
|
GB2456183A
(en)
|
2008-01-04 |
2009-07-08 |
Gw Pharma Ltd |
Anti-psychotic composition comprising cannabinoids and anti-psychotic medicament
|
|
GB2459637B
(en)
|
2008-01-21 |
2012-06-06 |
Gw Pharma Ltd |
New use for cannabinoids
|
|
US9023322B2
(en)
|
2008-03-26 |
2015-05-05 |
Stichting Sanammad |
Chewing gum compositions comprising cannabinoids
|
|
GB2478072B
(en)
|
2008-06-04 |
2012-12-26 |
Gw Pharma Ltd |
Anti-tumoural effects of cannabinoid combinations
|
|
GB2471987B
(en)
|
2008-06-04 |
2012-02-22 |
Gw Pharma Ltd |
Anti-tumoural effects of cannabinoid combinations
|
|
GB2475183B
(en)
|
2008-06-04 |
2011-11-23 |
Gw Pharma Ltd |
Cannabinoids in combination with non-cannabinoid chemotherapeutic agent that are selective estrogen receptor modulators
|
|
GB2478074B
(en)
|
2008-06-04 |
2012-12-26 |
Gw Pharma Ltd |
Anti-tumoural effects of cannabinoid combinations
|
|
US20110257256A1
(en)
|
2008-07-31 |
2011-10-20 |
Bionoria Research Gmbh |
Cannabinoids for use in treating or preventing cognitive impairment and dementia
|
|
WO2010031054A1
(en)
|
2008-09-15 |
2010-03-18 |
Biovista, Inc. |
Compositions and methods for treating epilepsy
|
|
US8809261B2
(en)
|
2008-10-31 |
2014-08-19 |
Elsohly Laboratories, Incorporated |
Compositions containing delta-9-THC-amino acid esters and process of preparation
|
|
WO2010127033A1
(en)
|
2009-04-28 |
2010-11-04 |
Alltranz Inc. |
Formulations of cannabidiol and methods of using the same
|
|
EP2424568A1
(en)
|
2009-04-29 |
2012-03-07 |
University Of Kentucky Research Foundation |
Cannabinoid-containing compositions and methods for their use
|
|
ES2409055T3
(es)
|
2009-06-29 |
2013-06-24 |
Bender Analytical Holding B.V. |
Sistema de suministro de fármacos que comprende polioxazolina y un agente bioactivo
|
|
GB2471523A
(en)
|
2009-07-03 |
2011-01-05 |
Gw Pharma Ltd |
Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy
|
|
US8735374B2
(en)
|
2009-07-31 |
2014-05-27 |
Intelgenx Corp. |
Oral mucoadhesive dosage form
|
|
US20110033529A1
(en)
|
2009-08-06 |
2011-02-10 |
Durga Prasad Samantaray |
Oral pharmaceutical paricalcitol formulations
|
|
JP2013505248A
(ja)
|
2009-09-16 |
2013-02-14 |
アラーガン インコーポレイテッド |
発作性疾患を治療するための組成物及び方法
|
|
GB2478595B
(en)
|
2010-03-12 |
2018-04-04 |
Gw Pharma Ltd |
Phytocannabinoids in the treatment of glioma
|
|
GB2487183B
(en)
|
2011-01-04 |
2018-10-03 |
Otsuka Pharma Co Ltd |
Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy
|
|
TWI583374B
(zh)
|
2010-03-30 |
2017-05-21 |
Ｇｗ伐瑪有限公司 |
使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途
|
|
GB2479153B
(en)
|
2010-03-30 |
2014-03-19 |
Gw Pharma Ltd |
The phytocannabinoid cannabidivarin (CBDV) for use in the treatment of epilepsy
|
|
AU2011264941B2
(en)
|
2010-06-07 |
2014-10-16 |
Suda Ltd |
Oral spray formulations and methods for administration of sildenafil
|
|
EP3459533A1
(en)
|
2010-08-04 |
2019-03-27 |
Grünenthal GmbH |
Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain
|
|
WO2012033478A1
(en)
|
2010-09-07 |
2012-03-15 |
Murty Pharmaceuticals, Inc. |
An improved oral dosage form of tetrahydrocannabinol and a method of avoiding and/or suppressing hepatic first pass metabolism via targeted chylomicron/lipoprotein delivery
|
|
US8895537B2
(en)
|
2010-10-29 |
2014-11-25 |
Infirst Healthcare Ltd. |
Compositions and methods for treating cardiovascular diseases
|
|
GB2487712B
(en)
*
|
2011-01-04 |
2015-10-28 |
Otsuka Pharma Co Ltd |
Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy
|
|
CA2737447A1
(en)
|
2011-04-27 |
2012-10-27 |
Antony Paul Hornby |
Hayley's comet
|
|
US9104993B2
(en)
|
2011-04-28 |
2015-08-11 |
Lantronix, Inc. |
Asset management via virtual tunnels
|
|
GB2491118B
(en)
|
2011-05-20 |
2015-12-30 |
Otsuka Pharma Co Ltd |
Cannabinoids for use in the treatment of neuropathic pain
|
|
GB201111261D0
(en)
|
2011-07-01 |
2011-08-17 |
Gw Pharma Ltd |
Cannabinoids for use in the treatment of neuro-degenerative diseases or disorders
|
|
US8808734B2
(en)
|
2011-07-11 |
2014-08-19 |
Full Spectrum Laboratories Limited |
Cannabinoid formulations
|
|
EP2747770A1
(en)
|
2011-08-26 |
2014-07-02 |
BIAL - Portela & Cª S.A. |
Treatments involving eslicarbazepine acetate or eslicarbazepine
|
|
GB2495118B
(en)
|
2011-09-29 |
2016-05-18 |
Otsuka Pharma Co Ltd |
A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
|
|
GB2496687A
(en)
|
2011-11-21 |
2013-05-22 |
Gw Pharma Ltd |
Tetrahydrocannabivarin (THCV) in the protection of pancreatic islet cells
|
|
US9254272B2
(en)
|
2011-11-30 |
2016-02-09 |
Sutter West Bay Hospitals |
Resorcinol derivatives
|
|
GB2504263B
(en)
|
2012-06-08 |
2015-09-16 |
Gw Pharma Ltd |
Synergistic therapies for neuroprotection
|
|
DE102012105063C5
(de)
|
2012-06-12 |
2023-09-14 |
Thc Pharm Gmbh The Health Concept |
Stabilisierung von Cannabinoiden und deren pharmazeutischen Zubereitungen
|
|
US9345771B2
(en)
|
2012-10-04 |
2016-05-24 |
Insys Development Company, Inc. |
Oral cannabinoid formulations
|
|
AU2014206036B2
(en)
|
2013-01-08 |
2017-11-02 |
Universidade De Sao Paulo - Usp |
Fluorinated CBD compounds, compositions and uses thereof
|
|
CN103110582A
(zh)
|
2013-03-04 |
2013-05-22 |
上海医药工业研究院 |
大麻酚类化合物微乳剂及其制备方法
|
|
WO2014145490A2
(en)
|
2013-03-15 |
2014-09-18 |
Biotech Institute, Llc |
Breeding, production, processing and use of specialty cannabis
|
|
LT2976074T
(lt)
|
2013-03-19 |
2020-03-25 |
Universitat Pompeu-Fabra |
Kanabinoido receptoriaus cb1 antagonistai, skirti naudoti gydant ligas, susijusias su neuronų dendritų anomalijomis
|
|
JP6300613B2
(ja)
|
2013-04-09 |
2018-03-28 |
キヤノン株式会社 |
トナー用樹脂およびトナー
|
|
US9549909B2
(en)
|
2013-05-03 |
2017-01-24 |
The Katholieke Universiteit Leuven |
Method for the treatment of dravet syndrome
|
|
GB2516814B
(en)
|
2013-06-19 |
2016-08-31 |
Otsuka Pharma Co Ltd |
Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer
|
|
GB2515312A
(en)
|
2013-06-19 |
2014-12-24 |
Gw Pharma Ltd |
The use of phytocannabinoids in the treatment of ovarian carcinoma
|
|
US20150181924A1
(en)
|
2013-10-31 |
2015-07-02 |
Michael R. Llamas |
Cannabidiol liquid composition for smoking
|
|
US9259449B2
(en)
|
2014-01-07 |
2016-02-16 |
Joshua Michael Raderman |
Method for modifying THC content in a lipid-based extract of cannabis
|
|
US10052339B2
(en)
|
2014-03-21 |
2018-08-21 |
Bodybio Inc. |
Methods and compositions for treating symptoms of diseases related to imbalance of essential fatty acids
|
|
CN103913888B
(zh)
|
2014-03-28 |
2016-08-17 |
京东方科技集团股份有限公司 |
一种彩膜基板、显示装置及彩膜基板的制造方法
|
|
US11331279B2
(en)
|
2014-05-29 |
2022-05-17 |
Radius Pharmaceuticals, Inc. |
Stable cannabinoid formulations
|
|
US12544389B2
(en)
|
2014-05-29 |
2026-02-10 |
Fresh Cut Development, Llc |
Stable cannabinoid formulations
|
|
CA2950424C
(en)
|
2014-05-29 |
2023-03-14 |
Insys Pharma, Inc. |
Stable cannabinoid formulations
|
|
US11911361B2
(en)
|
2014-05-29 |
2024-02-27 |
Radius Pharmaceuticals, Inc. |
Stable cannabinoid formulations
|
|
WO2015187988A1
(en)
|
2014-06-04 |
2015-12-10 |
Intellimedix |
Composition and methods of treating epilepsy and/or epilepsy-related disorders
|
|
GB2530001B
(en)
|
2014-06-17 |
2019-01-16 |
Gw Pharma Ltd |
Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
|
|
GB2527591A
(en)
|
2014-06-27 |
2015-12-30 |
Gw Pharma Ltd |
7-hydroxy cannabidiol (7-OH-CBD) for use in the treatment of non-alcoholic fatty liver disease (NAFLD)
|
|
GB2527590A
(en)
|
2014-06-27 |
2015-12-30 |
Otsuka Pharma Co Ltd |
Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancer
|
|
GB2527599A
(en)
|
2014-06-27 |
2015-12-30 |
Gw Pharma Ltd |
Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy
|
|
WO2016010827A1
(en)
|
2014-07-14 |
2016-01-21 |
Librede Inc. |
Production of cannabinoids in yeast
|
|
US9492438B2
(en)
|
2014-07-25 |
2016-11-15 |
Bette Pollard |
Amphiphilic pyridinum compounds to treat epilepsy and other disorders of the nervous system
|
|
WO2016022936A1
(en)
|
2014-08-07 |
2016-02-11 |
Murty Pharmaceuticals, Inc. |
An improved oral gastrointestinal dosage form delivery system of cannabinoids and/or standardized marijuana extracts
|
|
CA2859934A1
(en)
|
2014-09-22 |
2016-03-22 |
A. Paul Hornby |
Hayley's comet ii
|
|
GB2531283A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiols in the treatment of degenerative skeletal muscle diseases
|
|
GB2531280A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
GB2531282A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2531278A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
GB2531281A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
MX2017005277A
(es)
|
2014-10-21 |
2018-01-11 |
United Cannabis Corp |
Extractos de cannabis y métodos de preparación y uso de la misma.
|
|
CN104490873A
(zh)
|
2014-11-25 |
2015-04-08 |
邹丽萍 |
一种治疗儿童结节性硬化症的药物
|
|
CA2968929A1
(en)
|
2014-11-26 |
2016-06-02 |
One World Cannabis Ltd |
Synergistic use of cannabis for treating multiple myeloma
|
|
US9622145B2
(en)
|
2014-12-05 |
2017-04-11 |
At&T Intellectual Property I, L.P. |
Wireless network architecture for providing media content
|
|
US10172786B2
(en)
|
2014-12-16 |
2019-01-08 |
Axim Biotechnologies, Inc. |
Oral care composition comprising cannabinoids
|
|
US10751300B2
(en)
|
2015-01-25 |
2020-08-25 |
India Globalization Capital, Inc. |
Composition and method for treating seizure disorders
|
|
BR112017018944A2
(pt)
|
2015-03-02 |
2018-05-15 |
Afgin Pharma, Llc |
método de tratamento de um estado ou condição de doença em humanos com um medicamento carbinóide, e, método de tratamento de um estado ou condição de doença em um mamífero diferente de um humano com medicamento(s) carbinóide(s)
|
|
US20160338974A1
(en)
|
2015-03-02 |
2016-11-24 |
Afgin Pharma, Llc |
Topical regional neuro affective therapy with cannabinoid combination products
|
|
US10354246B1
(en)
|
2015-03-18 |
2019-07-16 |
Square, Inc. |
Cash transaction machine
|
|
EP3270896A4
(en)
|
2015-03-19 |
2018-09-12 |
One World Cannabis Ltd. |
Preparations of cannabis emulsions and methods thereof
|
|
US20160317468A1
(en)
|
2015-04-28 |
2016-11-03 |
Raman Sankar |
Uses of cannabidiol for treatment of infantile spasms
|
|
US10450302B2
(en)
|
2015-05-11 |
2019-10-22 |
Lundbeck La Jolla Research Center, Inc. |
Methods of treating inflammation or neuropathic pain
|
|
DK3302437T4
(da)
|
2015-05-28 |
2026-02-23 |
Fresh Cut Dev Llc |
Stabile cannabinoidformuleringer
|
|
WO2017203529A1
(en)
|
2016-05-24 |
2017-11-30 |
Bol Pharma Ltd. |
Compositions comprising cannabidiol and hyaluronic acid for treating inflammatory joint diseases
|
|
WO2016199148A1
(en)
|
2015-06-11 |
2016-12-15 |
One World Cannabis Ltd |
Novel cannabinoid combination therapies for multiple myeloma (mm)
|
|
GB2539472A
(en)
|
2015-06-17 |
2016-12-21 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
US20170008869A1
(en)
|
2015-07-10 |
2017-01-12 |
Noramco, Inc. |
Process for the production of cannabidiol and delta-9-tetrahydrocannabinol
|
|
GB2541191A
(en)
|
2015-08-10 |
2017-02-15 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2542155B
(en)
|
2015-09-09 |
2018-08-01 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of mental disorders
|
|
GB2542797A
(en)
|
2015-09-29 |
2017-04-05 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of inflammatory skin diseases
|
|
JP6676176B2
(ja)
|
2016-01-29 |
2020-04-08 |
ユニヴァーシティー オブ ミシシッピ |
生物学的に活性なカンナビジオール類似体
|
|
WO2017139496A1
(en)
|
2016-02-09 |
2017-08-17 |
Cevolva Biotech, Inc. |
Microbial engineering for the production of cannabinoids and cannabinoid precursors
|
|
GB2548873B
(en)
|
2016-03-31 |
2020-12-02 |
Gw Res Ltd |
Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
|
|
EP3462885B1
(en)
|
2016-05-27 |
2026-07-15 |
Fresh Cut Development, LLC |
Pharmaceutical formulation comprising cannabidiol and caprylic/capric triglyceride for use in the treatment of a disease or disorder
|
|
GB2551987A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB2551986A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Parenteral formulations
|
|
GB2551985B
(en)
|
2016-07-01 |
2019-01-30 |
Gw Res Ltd |
Novel formulation
|
|
IL246790A0
(en)
|
2016-07-14 |
2016-09-29 |
Friedman Doron |
Self-dissolving compounds of cannabinoids
|
|
GB2553139A
(en)
|
2016-08-25 |
2018-02-28 |
Gw Res Ltd |
Use of cannabinoids in the treatment of multiple myeloma
|
|
GB2557921A
(en)
|
2016-12-16 |
2018-07-04 |
Gw Res Ltd |
Use of cannabinoids in the treatment of angelman syndrome
|
|
US20200215022A1
(en)
|
2016-12-20 |
2020-07-09 |
Tilray, Inc. |
Novel cannabinoid compositions and methods of treating pediatric epilepsy
|
|
CN108236608B
(zh)
|
2016-12-27 |
2020-05-08 |
汉义生物科技（北京）有限公司 |
大麻二酚与氨己烯酸的药物组合物及其用途
|
|
GB2559774B
(en)
|
2017-02-17 |
2021-09-29 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB2560019A
(en)
|
2017-02-27 |
2018-08-29 |
Gw Res Ltd |
Use of cannabinoids in the treatment of leukaemia
|
|
JP2020517727A
(ja)
|
2017-04-27 |
2020-06-18 |
インシス・ディベロップメント・カンパニー・インコーポレイテッド |
安定なカンナビノイド製剤
|
|
GB2564383B
(en)
|
2017-06-23 |
2021-04-21 |
Gw Res Ltd |
Use of cannabidiol in the treatment of tumours assoicated with Tuberous Sclerosis Complex
|
|
IT201700085508A1
(it)
|
2017-07-26 |
2019-01-26 |
Inalco S R L |
Metodo per la produzione di cannabinoidi da varietà di canapa industriale
|
|
US10925525B2
(en)
|
2017-08-18 |
2021-02-23 |
Canon U.S.A., Inc. |
Combined pulse oximetry and diffusing wave spectroscopy system and control method therefor
|
|
GB201715919D0
(en)
|
2017-09-29 |
2017-11-15 |
Gw Res Ltd |
use of cannabinoids in the treatment of epilepsy
|
|
GB2568471B
(en)
|
2017-11-15 |
2022-04-13 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
WO2019100172A1
(en)
|
2017-11-27 |
2019-05-31 |
Beleave Inc. |
Extraction and purification of cannabinoid compounds
|
|
GB2568929A
(en)
|
2017-12-01 |
2019-06-05 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
EP3732813A1
(en)
|
2017-12-29 |
2020-11-04 |
Telefonaktiebolaget LM Ericsson (publ) |
Methods providing transmission and/or searching of encrypted data and related devices
|
|
GB2569961B
(en)
|
2018-01-03 |
2021-12-22 |
Gw Res Ltd |
Pharmaceutical
|
|
GB2572126B
(en)
|
2018-01-03 |
2021-01-13 |
Gw Res Ltd |
Pharmaceutical
|
|
GB2572125B
(en)
|
2018-01-03 |
2021-01-13 |
Gw Res Ltd |
Pharmaceutical
|
|
GB2572737A
(en)
|
2018-01-24 |
2019-10-16 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB201806953D0
(en)
|
2018-04-27 |
2018-06-13 |
Gw Res Ltd |
Cannabidiol Preparations
|
|
WO2019210210A1
(en)
|
2018-04-27 |
2019-10-31 |
Thomas Jefferson University |
Nanospun hemp-based materials
|
|
WO2019211795A1
(en)
|
2018-05-03 |
2019-11-07 |
Radient Technologies Inc. |
Continuous flow microwave-assisted extraction of a cannabis biomass
|
|
ES2987796T3
(es)
|
2018-10-30 |
2024-11-18 |
Gilead Sciences Inc |
Derivados de N-benzoil-fenilalanina como inhibidores de la integrina alfa4beta7 para el tratamiento de enfermedades inflamatorias
|
|
GB2579179A
(en)
|
2018-11-21 |
2020-06-17 |
Gw Res Ltd |
Cannabidiol-type cannabinoid compound
|
|
GB2580881A
(en)
|
2018-11-30 |
2020-08-05 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2580653A
(en)
|
2019-01-21 |
2020-07-29 |
Gw Res Ltd |
Use of cannabinoids in the treatment of comorbidities associated with epilepsy
|
|
GB2581517A
(en)
|
2019-02-22 |
2020-08-26 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2581987B
(en)
|
2019-03-06 |
2021-11-17 |
Gw Res Ltd |
Use of cannabidiol in combination with antibiotics
|
|
GB2583526A
(en)
|
2019-05-03 |
2020-11-04 |
Gw Res Ltd |
Use of cannabidiol in the treatment of tuberous sclerosis complex
|
|
GB2584140A
(en)
|
2019-05-23 |
2020-11-25 |
Gw Res Ltd |
Use of cannabidiol in the treatment of epileptic spasms
|
|
GB2584341B
(en)
|
2019-05-31 |
2023-03-01 |
Gw Res Ltd |
Cannabinoid formulations
|
|
CN110215443A
(zh)
|
2019-07-08 |
2019-09-10 |
云南绿新生物药业有限公司 |
一种抗衰老、改善睡眠软胶囊的制备方法
|
|
GB201910389D0
(en)
|
2019-07-19 |
2019-09-04 |
Gw Pharma Ltd |
Novel compounds, methods for their manufacture, and uses thereof
|
|
GB2586026A
(en)
|
2019-07-29 |
2021-02-03 |
Gw Res Ltd |
Use of cannabidol in the treatment of Dravet syndrome
|
|
CN110279617A
(zh)
|
2019-08-05 |
2019-09-27 |
云南绿新生物药业有限公司 |
一种含火麻精油的洗发水及其制备方法
|
|
GB2588576A
(en)
|
2019-08-27 |
2021-05-05 |
Gw Res Ltd |
Use of cannabinoids in the treatment of dyskinesia associated with Parkinson's disease
|
|
GB2589306A
(en)
|
2019-10-25 |
2021-06-02 |
Gw Res Ltd |
Use of cannabidiol preparations in the treatment of fragile X syndrome
|
|
GB2588457B
(en)
|
2019-10-25 |
2022-12-21 |
Gw Res Ltd |
Cannabinoid compound
|
|
GB2588461A
(en)
|
2019-10-25 |
2021-04-28 |
Gw Res Ltd |
Use of cannabidiol preparations in the treatment of absence epilepsy
|
|
GB2588460A
(en)
|
2019-10-25 |
2021-04-28 |
Gw Res Ltd |
Use of cannabidiol preparations in the treatment of temporal lobe epilepsy
|
|
GB201916846D0
(en)
|
2019-11-19 |
2020-01-01 |
Gw Res Ltd |
Cannabidiol-type cannabinoid compound
|
|
GB201916849D0
(en)
|
2019-11-19 |
2020-01-01 |
Gw Res Ltd |
Cannabidiol-type cannabinoid compound
|
|
GB201916974D0
(en)
|
2019-11-21 |
2020-01-08 |
Gw Res Ltd |
Cannabidol-type cannabinoid compound
|
|
GB201916977D0
(en)
|
2019-11-21 |
2020-01-08 |
Gw Res Ltd |
Cannibidol-type cannabinoid compound
|
|
GB201918846D0
(en)
|
2019-12-19 |
2020-02-05 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB202002754D0
(en)
|
2020-02-27 |
2020-04-15 |
Gw Res Ltd |
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
|
|
US11409517B2
(en)
|
2020-06-08 |
2022-08-09 |
Microsoft Technology Licensing, Llc |
Intelligent prefetching for OS components
|
|
GB202009321D0
(en)
|
2020-06-18 |
2020-08-05 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
GB2597312A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2597323A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2600077A
(en)
|
2020-07-20 |
2022-04-27 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2597309A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2597322A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2597306A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2597318A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2597308A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
|
|
GB2597317A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2597313A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2597311A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2597285A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2597321A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2597315A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2597281A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to brain injury
|
|
GB2597316A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB202013765D0
(en)
|
2020-09-02 |
2020-10-14 |
Gw Res Ltd |
Method of preparing cannabinoids
|
|
GB202014250D0
(en)
|
2020-09-10 |
2020-10-28 |
Gw Res Ltd |
Use of cannabidivarin in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
GB2598922A
(en)
|
2020-09-18 |
2022-03-23 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
US20220087951A1
(en)
|
2020-09-18 |
2022-03-24 |
GW Research Limited |
Use of cannabinoids in the treatment of epilepsy
|
|
US11160757B1
(en)
|
2020-10-12 |
2021-11-02 |
GW Research Limited |
pH dependent release coated microparticle cannabinoid formulations
|
|
GB2601755A
(en)
|
2020-12-08 |
2022-06-15 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with epilepsy syndromes
|
|
GB2602020A
(en)
|
2020-12-15 |
2022-06-22 |
Gw Res Ltd |
A method for evaluating the pro- or anti convulsive properties of test compounds
|
|
GB2602019A
(en)
|
2020-12-15 |
2022-06-22 |
Gw Res Ltd |
Cannabinoid derivative as a pharmaceutically active compound and method of preparation thereof
|
|
TW202237554A
(zh)
|
2020-12-15 |
2022-10-01 |
英商吉偉研究有限公司 |
新穎化合物、其製備方法及其用途
|
|
GB2606334A
(en)
|
2021-02-12 |
2022-11-09 |
Gw Res Ltd |
Use of cannabidivarin in the treatment of seizures associated with canine epilepsy
|
|
CA3216180A1
(en)
|
2021-05-12 |
2022-11-17 |
GW Research Limited |
6-hydroxy-cannabidiol-c4
|
|
CA3218211A1
(en)
|
2021-05-12 |
2022-11-17 |
Alan James SILCOCK |
Resorcinol derivative as a pharmaceutically active compound and method of preparation thereof
|
|
JP2024517326A
(ja)
|
2021-05-12 |
2024-04-19 |
ジーダブリュー・リサーチ・リミテッド |
レゾルシノール類、それら製造のための方法、及びその使用
|
|
CA3216179A1
(en)
|
2021-05-12 |
2022-11-17 |
Alan James SILCOCK |
Derivatives of cannabidiol-c4 for the treatment of epilepsy
|
|
EP4376820A1
(en)
|
2021-07-28 |
2024-06-05 |
GW Research Limited |
Use of cannabidiol in the treatment of epilepsy
|
|
US11815187B2
(en)
|
2022-01-26 |
2023-11-14 |
Maag Germany Gmbh |
3-port valve
|